Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer

Status Completed

Clinical Trial Summary

This clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer. Gathering information about genetic factors in women with an increased risk of ovarian cancer over time may help doctors learn more about the disease and find better methods of treatment and on-going care.

Clinical Trial Description

PRIMARY OBJECTIVES:

I. To determine the prospective incidence of ovarian cancer, fallopian tube cancer, breast cancer, primary peritoneal cancer, and all cancer among women at increased risk of ovarian cancer, with a special emphasis on women who are known breast cancer susceptibility gene (BRCA)1/2 mutation carriers.

II. To develop precise point estimates of these cancer rates among women who have undergone risk-reducing salpingo-oophorectomy and women who have elected screening.

III. To compare the cancer rates between these two groups of women. IV. To better characterize the similarities and differences in cancer risk between BRCA mutation-positive families and BRCA mutation-negative/family history-positive families.

V. To develop preliminary estimates of overall and cancer-specific mortality, stratified by mutation status (BRCA1-positive, BRCA2-positive, BRCA1/2-negative).

OUTLINE: This is a multicenter study.

Patients complete the Health Update Questionnaire annually for up to 5 years. The questionnaire focuses specifically on cancer risk, incidence, and mortality. Patients also receive ongoing communication (e.g., periodic newsletters, copies of study-related publications, etc.) to keep them informed regarding study-related research results, new research findings, new research opportunities for which patients may be eligible, and evolving clinical recommendations regarding hereditary breast/ovarian cancer. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01139957
Study type	Observational
Source	Gynecologic Oncology Group
Contact
Status	Completed
Phase
Start date	June 7, 2010
Completion date	April 10, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04996316` - MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals
Enrolling by invitation	`NCT05558917` - Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery	N/A
Completed	`NCT05526872` - A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening	N/A
Not yet recruiting	`NCT05178498` - Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Recruiting	`NCT05544123` - The Treatment Situation of Chinese County Population With Breast Cancer
Withdrawn	`NCT05191004` - Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC	Phase 1/Phase 2
Terminated	`NCT02890368` - Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides	Phase 1
Recruiting	`NCT01462903` - A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors	Phase 1
Completed	`NCT01422408` - Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy	Phase 2
Terminated	`NCT00770354` - Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer	Phase 2
Terminated	`NCT02810873` - Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer	N/A
Withdrawn	`NCT03185871` - Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses	Phase 2
Completed	`NCT02983279` - Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer	N/A
Active, not recruiting	`NCT02194387` - Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members	N/A
Recruiting	`NCT05406232` - Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Recruiting	`NCT03408353` - Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
Completed	`NCT01641068` - Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms	N/A
Withdrawn	`NCT04190433` - Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial	Phase 2
Recruiting	`NCT04799535` - Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Terminated	`NCT02923037` - Hatha Yoga in Breast Cancer Survivors	N/A